Study on Zervimesine for Alzheimer Disease Reaches Enrollment Target psychiatrictimes Homeschizophrenia September 7, 2025 byhealth0
FDA Releases Complete Response Letter on Declining MDMA-Assisted Therapy for PTSD psychiatrictimes Homeschizophrenia September 6, 2025 byhealth0
Contribution of Genetics, Environment, and Inflammation to Development of Severe Mental Illness psychiatrictimes Homeschizophrenia September 5, 2025 byhealth0
The August 2025 Special Report: Diversity psychiatrictimes Homeschizophrenia September 5, 2025 byhealth0
Can Holograms of Hope for Genocides Also be Applicable to Psychiatry? psychiatrictimes Homeschizophrenia September 4, 2025 byhealth0
Polypharmacy in Patients Treated With Clozapine psychiatrictimes Homeschizophrenia September 4, 2025 byhealth0
Harnessing Neuroplasticity for Brain Injury Recovery psychiatrictimes Homeschizophrenia September 4, 2025 byhealth0
Target Enrollment Completed for Phase 3 AFFIRM-1 Trial of BNC-210 in Social Anxiety Disorder psychiatrictimes Homeschizophrenia September 4, 2025 byhealth0
The Violins and People of Hope and Labor psychiatrictimes Homeschizophrenia September 4, 2025 byhealth0
